IBD Research Resource Center

Clinical ID	c2640
Identifier	EUCTR2019-000668-27-ES
Trial Title	Pilot Project for the Treatment of Perianal Disease through the Local Injection of Remsima Guided by Ultrasound. Number of cases.
Trial URL	Visit Original Page

Study Results	No results available
Conditions	Perianal disease (PD): alteration associated with inflammatory bowel disease (IBD) that includes fissures, ulcers, fistulas or abscesses, and is one of the most difficult aspects of treating IBD. Both by direct affectation of the sphincters and by the repeated surgeries that may be necessary to avoid septic conditions, there may be pain and incontinence to gases and feces, which supposes an important reduction of the quality of life of the patients.;Therapeutic area: Diseases [C] - Digestive System Diseases [C06]
Interventions	Trade Name: Remsima Product Name: Remsima Product Code: CT-P13 Pharmaceutical Form: Powder for concentrate for solution for infusion INN or Proposed INN: INFLIXIMAB CAS Number: 170277-31-3 Concentration unit: mg/ml milligram(s)/millilitre Concentration type: equal Concentration number: 4.15-

Sex Requirement	ALL
Age Requirement	-

Study Type	Interventional clinical trial of medicinal product
Phase	PHASE2